ARMISTICE CAPITAL, LLC - Q4 2018 holdings

$1.32 Billion is the total value of ARMISTICE CAPITAL, LLC's 71 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 96.1% .

 Value Shares↓ Weighting
SPY BuySPDR S&P 500 ETF TRput$374,880,000
+89.6%
1,500,000
+120.6%
28.41%
+139.4%
CLVS BuyCLOVIS ONCOLOGY INC$90,447,000
+88.2%
5,036,000
+207.8%
6.86%
+137.7%
CERC BuyCERECOR INC$58,556,000
-28.4%
18,128,799
+3.6%
4.44%
-9.5%
ENR NewENERGIZER HLDGS INC NEW$48,220,0001,068,000
+100.0%
3.66%
PLYA BuyPLAYA HOTELS & RESORTS NV$40,782,000
+26.3%
5,672,000
+69.2%
3.09%
+59.5%
EPC BuyEDGEWELL PERS CARE CO$38,097,000
-17.6%
1,020,000
+2.0%
2.89%
+4.0%
MNKKQ BuyMALLINCKRODT PUB LTD CO$36,340,000
-19.5%
2,300,000
+49.4%
2.75%
+1.7%
ENTA BuyENANTA PHARMACEUTICALS INC$35,415,000
-9.1%
500,000
+9.6%
2.68%
+14.7%
TPX BuyTEMPUR SEALY INTL INC$34,114,000
+544.9%
824,000
+724.0%
2.58%
+712.9%
DFRG BuyDEL FRISCOS RESTAURANT GROUP$32,375,000
+3.8%
4,528,000
+20.6%
2.45%
+31.2%
SRCL NewSTERICYCLE INC$31,480,000858,000
+100.0%
2.39%
AMAG SellAMAG PHARMACEUTICALS INC$28,527,000
-31.4%
1,878,000
-9.7%
2.16%
-13.4%
ATRS BuyANTARES PHARMA INC$28,016,000
-8.6%
10,300,000
+12.9%
2.12%
+15.4%
VYGR BuyVOYAGER THERAPEUTICS INC$26,658,000
-18.3%
2,836,000
+64.5%
2.02%
+3.2%
REGN SellREGENERON PHARMACEUTICALS$26,145,000
-13.7%
70,000
-6.7%
1.98%
+9.0%
PGNX SellPROGENICS PHARMACEUTICALS IN$23,940,000
-38.0%
5,700,000
-7.4%
1.81%
-21.7%
SJM SellSMUCKER J M CO$22,438,000
-57.6%
240,000
-53.5%
1.70%
-46.5%
WBT NewWELBILT INC$19,531,0001,758,000
+100.0%
1.48%
SJM NewSMUCKER J M COcall$18,698,000200,000
+100.0%
1.42%
FTDR NewFRONTDOOR INC$15,966,000600,000
+100.0%
1.21%
TJX NewTJX COS INC NEW$13,422,000300,000
+100.0%
1.02%
AZO NewAUTOZONE INC$13,413,00016,000
+100.0%
1.02%
SPPI NewSPECTRUM PHARMACEUTICALS INC$13,125,0001,500,000
+100.0%
1.00%
CVS NewCVS HEALTH CORPcall$13,104,000200,000
+100.0%
0.99%
SBBP BuySTRONGBRIDGE BIOPHARMA PLC$12,893,000
+0.3%
2,878,000
+8.6%
0.98%
+26.6%
ALXN NewALEXION PHARMACEUTICALS INC$12,073,000124,000
+100.0%
0.92%
ASRT BuyASSERTIO THERAPEUTICS INC$11,834,000
-32.9%
3,278,000
+9.3%
0.90%
-15.3%
FL NewFOOT LOCKER INC$11,278,000212,000
+100.0%
0.86%
CVS BuyCVS HEALTH CORP$10,352,000
+31.5%
158,000
+58.0%
0.78%
+66.0%
PTCT NewPTC THERAPEUTICS INC$10,296,000300,000
+100.0%
0.78%
PRTK BuyPARATEK PHARMACEUTICALS INC$10,096,000
-13.3%
1,968,000
+64.0%
0.76%
+9.4%
CLLS SellCELLECTIS S Asponsored ads$9,807,000
-42.1%
589,000
-1.8%
0.74%
-26.9%
SLDB BuySOLID BIOSCIENCES INC$8,898,000
+15.0%
332,000
+102.4%
0.67%
+45.3%
MRKR NewMARKER THERAPEUTICS INC$8,258,0001,488,000
+100.0%
0.63%
EYEG BuyEYEGATE PHARMACEUTICALS INC$8,029,000
+54.1%
17,262,853
+2.7%
0.61%
+94.6%
ATEC BuyALPHATEC HOLDINGS INC$7,645,000
-31.3%
3,338,414
+1.2%
0.58%
-13.3%
OLLI NewOLLIES BARGAIN OUTLT HLDGS I$7,183,000108,000
+100.0%
0.54%
FUN NewCEDAR FAIR L Pdepositry unit$7,095,000150,000
+100.0%
0.54%
ACHN BuyACHILLION PHARMACEUTICALS IN$6,837,000
-7.1%
4,300,000
+115.0%
0.52%
+17.2%
TGT NewTARGET CORP$6,609,000100,000
+100.0%
0.50%
AAP NewADVANCE AUTO PARTS INC$6,613,00042,000
+100.0%
0.50%
VLRX NewVALERITAS HLDGS INC$6,461,00019,850,000
+100.0%
0.49%
INCY NewINCYTE CORP$6,359,000100,000
+100.0%
0.48%
ZFGN BuyZAFGEN INC$6,227,000
-54.2%
1,258,000
+8.1%
0.47%
-42.2%
FIVE NewFIVE BELOW INC$6,139,00060,000
+100.0%
0.46%
 PERNIX THERAPEUTICS HLDGS INdbcv 4.250% 4/0$5,723,000
-40.0%
21,760,0000.0%0.43%
-24.1%
ADMS NewADAMAS PHARMACEUTICALS INC$5,619,000658,000
+100.0%
0.43%
VICL  VICAL INC$5,145,000
-13.9%
4,360,5000.0%0.39%
+8.6%
ALIM  ALIMERA SCIENCES INC$4,981,000
-26.7%
6,936,0000.0%0.38%
-7.4%
CRSP NewCRISPR THERAPEUTICS AGnamen akt$4,914,000172,000
+100.0%
0.37%
FLXN NewFLEXION THERAPEUTICS INC$4,528,000400,000
+100.0%
0.34%
OVID NewOVID THERAPEUTICS INC$3,872,0001,600,000
+100.0%
0.29%
NAKD BuyNAKED BRAND GROUP LIMITED$3,256,000
-33.8%
3,892,000
+112.9%
0.25%
-16.3%
CPRX SellCATALYST PHARMACEUTICALS INC$2,650,000
-58.1%
1,380,000
-17.5%
0.20%
-47.0%
ASMB NewASSEMBLY BIOSCIENCES INC$2,262,000100,000
+100.0%
0.17%
SRRA NewSIERRA ONCOLOGY INC$2,112,0001,600,000
+100.0%
0.16%
MDGSW NewMEDIGUS LTD*w exp 07/23/202$1,749,0001,285,715
+100.0%
0.13%
ORMP SellORAMED PHARM INC$1,629,000
-46.4%
542,944
-13.0%
0.12%
-32.4%
DYNT BuyDYNATRONICS CORP$1,532,000
-2.4%
561,000
+1.8%
0.12%
+23.4%
APRI  APRICUS BIOSCIENCES INC$883,000
-38.1%
4,600,0000.0%0.07%
-22.1%
ROX BuyCASTLE BRANDS INC$886,000
+728.0%
1,042,000
+942.0%
0.07%
+1016.7%
CTXR BuyCITIUS PHARMACEUTICALS INC$768,000
+668.0%
738,431
+1163.8%
0.06%
+866.7%
ACHV NewACHIEVE LIFE SCIENCE INC$542,000448,000
+100.0%
0.04%
UAA NewUNDER ARMOUR INCcl a$530,00030,000
+100.0%
0.04%
PULM NewPULMATRIX INC$414,0001,723,254
+100.0%
0.03%
SYN NewSYNTHETIC BIOLOGICS INC$312,000556,904
+100.0%
0.02%
CUR NewNEURALSTEM INC$185,000590,000
+100.0%
0.01%
NewTENAX THERAPEUTICS INC$102,00084,590
+100.0%
0.01%
AYTU NewAYTU BIOSCIENCE INC$79,000100,000
+100.0%
0.01%
ONTX SellONCONOVA THERAPEUTICS INC$62,000
-92.4%
29,216
-73.7%
0.01%
-89.8%
RTTR SellRITTER PHARMACEUTICALS INC$30,000
-91.2%
50,771
-72.1%
0.00%
-90.0%
TTNP ExitTITAN PHARMACEUTICALS INC DE$0-220,000
-100.0%
-0.00%
VXRT ExitVAXART INC$0-150,000
-100.0%
-0.03%
PTIE ExitPAIN THERAPEUTICS INC$0-2,164,000
-100.0%
-0.13%
IPCIF ExitINTELLIPHARMACEUTICS INTL IN$0-860,000
-100.0%
-0.14%
T ExitAT&T INC$0-100,000
-100.0%
-0.20%
JCPNQ ExitPENNEY J C INCcall$0-2,300,000
-100.0%
-0.23%
PDLI ExitPDL BIOPHARMA INC$0-1,800,000
-100.0%
-0.28%
CMRX ExitCHIMERIX INC$0-1,300,000
-100.0%
-0.30%
APRN ExitBLUE APRON HLDGS INCcall$0-3,000,000
-100.0%
-0.31%
MED ExitMEDIFAST INC$0-24,000
-100.0%
-0.32%
FTCH ExitFARFETCH LTDord sh cl a$0-200,000
-100.0%
-0.33%
NVLNF ExitNOVELION THERAPEUTICS INC$0-1,856,000
-100.0%
-0.33%
TLRDQ ExitTAILORED BRANDS INC$0-300,000
-100.0%
-0.45%
LULU ExitLULULEMON ATHLETICA INC$0-50,000
-100.0%
-0.49%
FB ExitFACEBOOK INCcl a$0-50,000
-100.0%
-0.49%
FND ExitFLOOR & DECOR HLDGS INCcl a$0-300,000
-100.0%
-0.54%
BDSI ExitBIODELIVERY SCIENCES INTL IN$0-3,292,000
-100.0%
-0.55%
EAT ExitBRINKER INTL INC$0-200,000
-100.0%
-0.56%
RDUS ExitRADIUS HEALTH INC$0-658,000
-100.0%
-0.70%
ONCE ExitSPARK THERAPEUTICS INC$0-228,000
-100.0%
-0.75%
BLUE ExitBLUEBIRD BIO INC$0-88,000
-100.0%
-0.77%
GPS ExitGAP INC DEL$0-524,000
-100.0%
-0.91%
BBY ExitBEST BUY INC$0-200,000
-100.0%
-0.95%
MDGL ExitMADRIGAL PHARMACEUTICALS INC$0-80,000
-100.0%
-1.03%
PETS ExitPETMED EXPRESS INC$0-532,000
-100.0%
-1.05%
QRTEA ExitQURATE RETAIL INC$0-900,000
-100.0%
-1.20%
VNDA ExitVANDA PHARMACEUTICALS INC$0-900,000
-100.0%
-1.24%
SGMS ExitSCIENTIFIC GAMES CORP$0-900,000
-100.0%
-1.37%
DESP ExitDESPEGAR COM CORP$0-1,564,000
-100.0%
-1.58%
HAIN ExitHAIN CELESTIAL GROUP INC$0-1,000,000
-100.0%
-1.63%
RL ExitRALPH LAUREN CORPcl a$0-218,000
-100.0%
-1.80%
CAR ExitAVIS BUDGET GROUP$0-1,000,000
-100.0%
-1.93%
KORS ExitMICHAEL KORS HLDGS LTD$0-536,000
-100.0%
-2.21%
HBI ExitHANESBRANDS INC$0-2,000,000
-100.0%
-2.21%
HOG ExitHARLEY DAVIDSON INC$0-824,000
-100.0%
-2.24%
UTHR ExitUNITED THERAPEUTICS CORP DEL$0-292,000
-100.0%
-2.24%
INCY ExitINCYTE CORPcall$0-700,000
-100.0%
-2.90%
HAIN ExitHAIN CELESTIAL GROUP INCcall$0-2,000,000
-100.0%
-3.26%
CAKE ExitCHEESECAKE FACTORY INCcall$0-1,100,000
-100.0%
-3.54%
CPB ExitCAMPBELL SOUP COcall$0-2,000,000
-100.0%
-4.40%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ENANTA PHARMACEUTICALS INC30Q3 20232.7%
SPDR S&P 500 ETF TR28Q3 202329.5%
MADRIGAL PHARMACEUTICALS INC27Q3 20232.9%
VANDA PHARMACEUTICALS INC26Q3 20219.4%
REGENERON PHARMACEUTICALS25Q3 20233.2%
ENERGIZER HLDGS INC NEW22Q2 20233.7%
ANTARES PHARMA INC21Q3 20206.6%
INCYTE CORP21Q3 20232.8%
VOYAGER THERAPEUTICS INC21Q3 20232.0%
BLUEBIRD BIO INC20Q4 20211.8%

View ARMISTICE CAPITAL, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ARMISTICE CAPITAL, LLC Q4 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Avalo Therapeutics, Inc.June 28, 2023588,8504.7%
Addex Therapeutics Ltd.February 16, 2023675,2955.0%
Arcadia Biosciences, Inc.February 14, 20232,675,40910.0%
Avinger IncFebruary 14, 2023789,40010.0%
Baudax Bio, Inc.February 14, 20231,165,7095.0%
BIORA THERAPEUTICS, INC.February 14, 202312,989,6485.7%
Bit Digital, IncFebruary 14, 20233,161,8893.7%
Bruush Oral Care Inc.February 14, 20231,122,92210.0%
CATALYST PHARMACEUTICALS, INC.Sold outFebruary 14, 202300.0%
Clarus Therapeutics Holdings, Inc.February 14, 20232,732,1695.0%

View ARMISTICE CAPITAL, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View ARMISTICE CAPITAL, LLC's complete filings history.

Compare quarters

Export ARMISTICE CAPITAL, LLC's holdings